Global Medical REIT (GMRE) Misses Q4 FFO and Revenue Estimates

Global Medical REIT (GMRE) came out with quarterly funds from operations (FFO) of $0.23 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to FFO of $0.24 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an FFO surprise of -4.17%. A quarter ago, it was expected that this real estate investment trust would post FFO of $0.23 per share when it actually produced FFO of $0.23, delivering no surprise.

Over the last four quarters, the company has not been able to surpass consensus FFO estimates.

Global Medical REIT, which belongs to the Zacks REIT and Equity Trust - Other industry, posted revenues of $32.96 million for the quarter ended December 2023, missing the Zacks Consensus Estimate by 8.02%. This compares to year-ago revenues of $36.31 million. The company has not been able to beat consensus revenue estimates over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future FFO expectations will mostly depend on management's commentary on the earnings call.

Global Medical REIT shares have lost about 16.4% since the beginning of the year versus the S&P 500's gain of 6.3%.

What's Next for Global Medical REIT?

While Global Medical REIT has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's FFO outlook. Not only does this include current consensus FFO expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Global Medical REIT: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus FFO estimate is $0.24 on $36.34 million in revenues for the coming quarter and $0.98 on $146.67 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust - Other is currently in the top 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Summit Hotel Properties (INN), has yet to report results for the quarter ended December 2023. The results are expected to be released on February 28.

This real estate investment trust specializing in higher end hotels is expected to post quarterly earnings of $0.21 per share in its upcoming report, which represents a year-over-year change of -16%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Summit Hotel Properties' revenues are expected to be $175.76 million, up 2% from the year-ago quarter.

Just Released: Zacks Top 10 Stocks for 2024

Hurry – you can still get in early on our 10 top tickers for 2024. Hand-picked by Zacks Director of Research, Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2024. You can still be among the first to see these just-released stocks with enormous potential.

See New Top 10 Stocks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Global Medical REIT Inc. (GMRE) : Free Stock Analysis Report

Summit Hotel Properties, Inc. (INN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.